University of Nebraska - Lincoln

DigitalCommons@University of Nebraska - Lincoln
Roman L. Hruska U.S. Meat Animal Research
Center

U.S. Department of Agriculture: Agricultural
Research Service, Lincoln, Nebraska

1-16-2021

iTRAQ-based proteomic analysis of bovine pre-ovulatory plasma
and follicular fluid
P A. Afedi
South Dakota State University

E L. Larimore
South Dakota State University

R A. Cushman
U.S. Meat Animal Research Center, Clay Center

D Raynie
South Dakota State University

G A. Perry
South Dakota State University, George.Perry@ag.tamu.edu

Follow this and additional works at: https://digitalcommons.unl.edu/hruskareports

Afedi, P A.; Larimore, E L.; Cushman, R A.; Raynie, D; and Perry, G A., "iTRAQ-based proteomic analysis of
bovine pre-ovulatory plasma and follicular fluid" (2021). Roman L. Hruska U.S. Meat Animal Research
Center. 476.
https://digitalcommons.unl.edu/hruskareports/476

This Article is brought to you for free and open access by the U.S. Department of Agriculture: Agricultural Research
Service, Lincoln, Nebraska at DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion
in Roman L. Hruska U.S. Meat Animal Research Center by an authorized administrator of
DigitalCommons@University of Nebraska - Lincoln.

Domestic Animal Endocrinology 76 (2021) 106606

Contents lists available at ScienceDirect

Domestic Animal Endocrinology
journal homepage: www.journals.elsevier.com/domestic-animal-endocrinology

iTRAQ-based proteomic analysis of bovine pre-ovulatory
plasma and follicular ﬂuid ✩,✩✩
P.A. Afedi a, E.L. Larimore b, R.A. Cushman c, D. Raynie a, G.A. Perry b,∗
a

Department of Chemistry and Biochemistry, South Dakota State University, Brookings, SD, USA
Department of Animal Science, South Dakota State University, Brookings, SD, USA
c
USDA-ARS, U.S. Meat Animal Research Center, Clay Center, NE 68933, USA
b

a r t i c l e

i n f o

Article history:
Received 28 September 2020
Received in revised form 5 January 2021
Accepted 16 January 2021

Keywords:
Estradiol
Proteomics
Follicular ﬂuid
Plasma
Reproductive associated protein

a b s t r a c t
Bovine follicular ﬂuid (FF) creates a unique microenvironment in follicles necessary for follicle growth, oocyte maturation, and estradiol (E2) production. The objective of this study
was to analyze changes in proteins in FF and plasma (PL) from animals with high E2 (HE2)
or low E2 (LE2) during the preovulatory period. Beef cows were synchronized, and follicular
dynamics and ovulatory response were monitored using transrectal ultrasonography. Nine
cows were selected and slaughtered, blood samples were collected at slaughter and FF was
aspirated from dominant follicles (DF; >10 mm). Abundant proteins (albumin, IgG, IgA, and
alpha-1-antitrypsin) were depleted from both PL and FF. Peptides were labeled with iTRAQ
reagents and quantiﬁed using 2-dimentional liquid chromatography ESI-based mass spectrometry. Estradiol was associated with protein changes in PL and FF. Protein expression
changes between FF HE2 and FF LE2 were greater than between PL HE2 and PL LE2. There
were 15 up-regulated proteins and 10 down-regulated proteins in FF HE2 compared to FF
LE2, and 7 proteins up-regulated and 9 proteins down-regulated in PL HE2 compared to
PL LE2. Several of the differentially expressed proteins function in follicle development and
were mainly categorized under cellular process and metabolic process. Pathway analysis
identiﬁed the up- and down-regulated proteins were predominantly associated with the
complement and coagulation cascades. The data demonstrate E2 regulates a wide range of
reproductive associated proteins in bovine PL and FF and can provide the basis for further
investigation of speciﬁc processes involved in such regulation.
© 2021 Elsevier Inc. All rights reserved.
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1. Introduction
Follicular ﬂuid (FF) provides a unique microenvironment for developing oocytes. It contains substances that
primarily originate from circulating blood and from secretions by granulosa cells (GCs), theca cells and the oocyte
[1]. Proteins are a major proportion of the FF with total
concentration comparable with that in plasma [2]; however, the composition of the proteins in FF changes with
follicle development [3,4] which indicates their involvement in the development of the follicle and competence
of the oocyte. Accordingly, FF proteins have been implicated in oocyte meiosis, ovulation, formation of the corpus
luteum and fertilization [1]. Thus, FF proteins can reﬂect
the physiological condition of the follicle and may serve
as biomarkers for follicle growth and maturation. Blood
plasma proteins are also important indicator of folliculogenesis and ovulation because of the signiﬁcant amount
of proteins able to cross the blood-follicular barrier during
folliculogenesis.
Estrogens are an important component of FF. During
the steroidogenesis, androgens produced in the theca cells
traverse the basement membrane of the neighboring GCs
where they are converted by cytochrome P450 aromatase
(CYP19A1) under the inﬂuence of follicle stimulating hormone (FSH) to estrogens [5], with Estradiol-17β (E2) being
the principal form of estrogen present [5,6]. The preovulatory follicle is reported to have the highest intra-follicular
levels of E2 mainly because of the large number of GCs and
its capacity for androgen aromatization [5].
In developing follicles, E2 stimulates proliferation and
differentiation of GCs [5], and promotes growth, gapjunction formation, antrum formation and inhibition of
atresia [7]. Perry et al. [8] reported that, among cows
exhibiting standing estrus, peak concentration of E2 were
greater and positively associated with follicle size, but this
association was not found in cows not exhibiting standing
estrus. Cows with increased concentration of circulating
E2 had an up-regulation of the steroidogenic pathway
during the preovulatory period as evidenced by increased
concentrations of steroidogenic associated enzymes
3β -hydroxysteroid dehydrogenase (3β -HSD), CYP19A1,
cytochrome P450 side-chain cleavage enzyme (CYP11A1),
and steroidogenic products estradiol and androstenedione
[9]. An important means by which E2 achieves its regulatory reproductive functions is via regulation of proteins
and protein receptors involved in their relevant functions.
Quantitative shot-gun proteomics, incorporating isobaric
labeling techniques such as isobaric tags for relative and
absolute quantitation (iTRAQ) and tandem mass tags
(TMT), allow measuring of protein changes with greater
precision and accuracy than label-free methods [10]. Thus
this method can be applied to determine changes in the
expression of several proteins in a short period. Its application to FF is beneﬁcial considering the large number
and diversity of the FF proteome. Ferrazza et al. [3] recently utilized TMT labels and identiﬁed 22 differentially
expressed proteins in bovine FF between different stages
of follicle development. The group also demonstrated a
correlation between some of the differentially expressed
proteins (modiﬁed ﬁbrinogen, alpha-2-macroglobulin, plas-

minogen, immunoglobulin M heavy chain, and spondin-1)
and concentration of E2 or progesterone. The objective of
this study was to use the iTRAQ proteomic approach to
quantitatively measure changes in PL and FF proteomes
between animals with high or low preovulatory circulating
concentrations of E2. We speciﬁcally hypothesized that
proteins involved in the ﬁnal stages of folliculogenesis
and the ovulatory process would be present in greater
abundance in the FF of animals with increased circulating
concentrations of E2.
2. Materials and methods
2.1. Animals’ experimental design
All procedures were approved by the South Dakota
State University Institutional Animal Care and Use Committee. Samples in the present study were collected from
a previous study to characterize changes in steroidogenic
enzymes and FF steroid concentrations [9]. Brieﬂy, 32 cycling nonlactating beef cows (age = 4–10 yrs; mean BCS of
5.5) were synchronized by an injection of GnRH (100 mg
as 2 mL of Factrel, intramuscularly; Zoetis on day-7 and
prostaglandin F2α (PGF2α ) 25 mg as 5 mL of Lutalyse intramuscularly (Zoetis, Florham Park, NJ, USA) on day 0. Estrus was monitored every 3 h from PG on day 0 until hour
33 and at slaughter (hour 36–42) with the aid of EstroTect
(Western Point, Inc, Apple Valley, MN, USA) estrus detection aids. Ovaries of all cows were examined on day-7, -4,
and 0 by transrectal ultrasonography using an Aloka 500V
ultrasound with a 7.5-MHz linear probe (Aloka, Wallingford, CT, USA) to assess follicular dynamics and ovulatory
response. Ten cows that were determined to initiate a new
follicular wave by day-4 (as determined by a cohort of
growing follicle all less than 9 mm) were slaughtered by
captive bolt and exsanguination on day 2 (hour 36–42) for
ovary collection. All cows had a CL present and a new follicular wave that had been initiated between days-7 and
-4. This would mean all follicles were growing in the presence of progesterone and would be at a similar stage of
growth. However, ovaries were collected from 9 out of the
10 cows as one was determined to have a follicular cyst
at time of slaughter and was excluded. Thus, a total of 9
cows were used for further study and data analysis. Estradiol (E2) concentrations in PL and FF were measured by
radioimmunoassays (RIA) according to procedures as previously described [11]. Animals were classiﬁed based on
circulating E2 concentrations in PL at 36 hrs after PGF2α
as either high E2 (peak PL estradiol 9.07 ± 0.89 pg/mL;
PL: n = 4, FF concentrations were 1,565 ± 196.0 ng/mL) or
low E2 (peak PL estradiol 3.22 ± 0.79 pg/mL; PL: n = 5,
FF concentrations were 398 ± 175.0 ng/mL). Animals were
classiﬁed into high and low E2 classiﬁcation according to
Jinks et al. [12] (Peak estradiol >8.4 pg mL at 48 hrs after
PGF2α ). Concentrations of E2 and changes in the steroidogenic pathway have previously been reported by Larimore
and coworkers [9].
2.2. Follicular ﬂuid (FF) and blood samples collection
All animals were harvested in the South Dakota State
University Meat Laboratory. Within minutes of slaughter

P.A. Afedi, E.L. Larimore, R.A. Cushman et al. / Domestic Animal Endocrinology 76 (2021) 106606

the reproductive tract was collected. Follicular ﬂuid (FF)
was aspirated from dominant follicles (DF; >10 mm in diameter) and the GCs were separated from the FF by centrifugation (1,0 0 0 x g for 1 min). The FF was place in RNase
Free Tubes (USA Scientiﬁc), snap frozen in liquid nitrogen
and stored at -80°C until ready for analysis. Blood samples
were collected at exsanguination to provide better comparison to the FF collected at slaughter. To obtain plasma,
blood collected at slaughter was placed in EDTA vacutainer
tubes (Beckman Dickerson) and centrifuged at 1,200 x g for
30 min at 4°C. The plasma supernatant was snap frozen
in liquid nitrogen and stored at -80°C until ready for proteomic analysis.

2.3. Depletion and Coomassie Bradford assay quantitation
Depletion of the different bovine ﬂuids (PL HE2, PL LE2,
FF HE2, and FF LE2) were performed using the High Capacity Multiple Aﬃnity Spin Cartridge (MARS Hu-6HC) #
5188-5341 (Agilent Technologies, CA, USA) as previously
reported [13]. Protein content in depleted samples was
quantiﬁed using Coomassie (Bradford) assay kit (Pierce
Biotechnology, IL, USA) according to manufacturer’s instruction. Bovine serum albumin (Thermo Scientiﬁc, IL,
USA) was used as a standard for making a calibration
curve. Standard (2 mg/mL) was diluted with 50 mM TEAB
and the calibration curve covered a concentration range of
0.00 to 1500 μg/mL.

2.4. Reduction, alkylation, digestion, and iTRAQ labeling of
proteins
Fifty micrograms of each of 4 depleted bovine samples
(PL LE2, PL HE2, FF LE2, and FF HE2) containing high or
low E2 were pooled and vacuum dried (Labconco, Kansas,
MO, USA) at 4°C. The dried proteins were prepared with
iTRAQ reagents according to manufacturer protocol (Applied Biosystems, Foster City, CA, USA). Brieﬂy, the dried
proteins were resuspended in 25 μL 1M TEAB solution. The
proteins were denatured with 1 μL 2% SDS solution, reduced with 2 μL 50 mM tris-(2-carboxy) ethylphosphine
hydrochloride (TCEP), and alkylated with1 μL of freshly
prepared 84 mM iodoacetamide solution and incubated in
dark room temperature for 30 min. Each sample (50 μg)
was digested overnight at 37°C with 10 μL of freshly prepared 1 μg/μL TPCK treated trypsin solution, P/N 4370282
(Ab Sciex Pte Ltd, MA, USA). iTRAQ reagents 114, 115, 116,
and 117 were each resuspended in 70 μL ethanol and
added individually to the 4 digested PL and FF protein
samples. The samples were incubated at room temperature for 1 h and the reaction quenched by adding 100 μL of
HPLC grade water and incubating at room temperature for
30 min. The iTRAQ-labeled peptides were vacuum dried at
4°C, cleaned with Zeba desalting spin columns according
to vendor instructions (Pierce, Rockford, IL, USA) and then
vacuum dried at 4°C. Samples were stored at -80°C until
ready for analysis.
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2.5. Off-line strong cation exchange (SCX) separation
The iTRAQ-labeled peptides were separated using
Cation Exchange Cartridge, # 4326695, Opti-Lynx Quick
Connect Hardware, # 4326688, and Cation Exchange Buffer
Pack, # 4326747 (Applied Biosystems, Foster City, CA, USA
USA). The iTRAQ-labeled dried peptides were each diluted
10-fold with Load Buffer (10 mM KH2 PO4 in 25% ACN; pH
3) and the 4 samples combined in one new vial. Equilibration of the SCX cartridge was done with 1 mL of
Clean Buffer (10 mM KH2 PO4 in 25% ACN/1 M KCl; pH 3)
followed by 2-mL Load Buffer. The mixed iTRAQ labeled
peptides were then loaded onto the SCX cartridge. Excess
iTRAQ reagents and salts in the cartridge were removed by
washing the cartridge with 1 mL of Load Buffer. The bound
peptides on the cartridge were eluted by sequential injection of 500 μL of a series of salt solutions: 0, 30, 40, 50, 60,
70, 85, 100, 130, 160, 350, 500, and 1,000 mM KCl in Load
Buffer. The ﬂow rate of elution was ~1 drop/s. Each eluted
fraction and wash solution was cleaned with Zeba desalting spin columns according to vendor instructions (Pierce,
Rockford, IL, USA). Puriﬁed peptides were vacuum dried at
4°C (Labconco, Kansas, MO, USA) and stored at -80°C until
further analysis.
2.6. Nano-LC-MS/MS analysis
Aliquots of the dried SCX peptide fractions were analyzed using the Thermo-Fisher Finnigan LTQ mass spectrometer equipped with a nano electrospray source (New
Objective, Woburn, MA, USA) and coupled with a nano-LC
separation system (Eksigent nanoLC 1D-plus). The LC system is equipped with an autosampler (Spark Holland 920
Endurance Autosampler). Each peptide fraction was resuspended in 10 μL of water/ACN/formic acid (95%/5%/0.1%)
and then 3 μL loaded onto IntegraFrit Sample trap, ProteoPep II C18, 300 Å, 5 μm, 100 μm × 25 mm (New
Objective, Inc., Woburn, MA). The retained peptides were
washed isocratically with water premixed with 0.1% formic
acid pumped from channel 1A to remove any excess
reagents. Peptide separation was performed on an IntegraFrit Analytical Column (ProteoPep II C18, 75 μm × 100
mm, New Objective, Inc., Woburn, MA) with a multistep
4-h gradient using solvent A (water premixed with 0.1%
formic acid) and solvent B (acetonitrile premixed with 0.1%
formic acid) at a ﬂow rate of 200 nL/min. The gradient
started at 5% solvent B and was held for 5 min, then linearly increased to 50% solvent B at 205 min and to 95%
solvent B at 213 min and ﬁnally held at 95% solvent B for
5 min before allowing to return to initial 5% solvent B at
223 min. Column reequilibration with initial 5% solvent B
was done for 17 min.
The LTQ mass spectrometer was operated in a datadependent mode. The full MS spectra were acquired in
positive mode within a range of 400 to 1,800 m/z. The top
4 most intense ions in the acquired full mass scan were
selected for followed pulsed Q dissociation (PQD) in LTQ.
The Q activation and time was set respectively at 0.7 eV
and 0.1 ms. The maximum ion injection times used were
50 ms for the MS scan and 120 ms for the MS/MS scans.
One microscan of full MS was performed. The automatic
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gain control target settings were 3.0 × 104 for the MS scan
mode and 1.0 × 104 for the MS/MS scan mode. The normalized collision energy was 29.5% and the isolation window employed was 2 m/z. The dynamic exclusion settings
utilized were repeat count 2, exclusion duration 25 s, exclusion list size 500, exclusion mass width low 0.5 and exclusion mass width high 1.5.
2.7. Protein identiﬁcation and quantiﬁcation
The LC-MS/MS raw data from nanoLC-LTQ were correlated to theoretical fragmentation patterns of tryptic peptide sequences in bovine protein fasta database using SEQUEST search engine embedded in Proteome Discoverer
(version 2.1; Thermo Fisher Scientiﬁc). The search parameters included were as follows: ﬁxed cysteine modiﬁcations
of +57 Da for carbamidomethyl-cysteines, +144 Da for
lysine-iTRAQ labeling and N-terminal peptides; dynamic
modiﬁcations allowing +16 with methionines for methionine sulfoxide and + 144 Da for Y-iTRAQ labeling; restricted
to trypsin digested peptides and allowed for 2 missed
cleavages; precursor mass range was 350 to 5,0 0 0 Da; peptide mass tolerance of 2.5 Da and fragment mass tolerance
of ±0.8 Da; target false discovery rate (FDR) strict was 0.01
and FDR relaxed was 0.05; most conﬁdent centroid was selected for peak integration method and a 0.25 Da integration window tolerance was allowed. The proteins matched
with at least one unique peptide at minimum 95% conﬁdence were considered positive identiﬁcations. The FDR
is a statistical measure of the certainty of the identiﬁcations and is calculated using F values. The F-value calculation factors the primary score from the spectra library
search (Dot Score) and the Dot Bias Score which is an indication of the number of spectra used in determining the
Dot Score.
The relative quantiﬁcation of proteins in the samples
was performed with the Proteome Discover (1.2). The
quantiﬁcation utilized the relative peak intensities of the
iTRAQ reporter ions derived from MS/MS spectra of all
unique peptides that represented each protein. iTRAQ ratios of the reporter ions were calculated using reporter
ions representing any 2 samples. The ﬁnal ratios obtained
from the relative protein quantiﬁcations were normalized
according to the median protein quantiﬁcation ratio. The
protein ratios were the median ratio of the corresponding peptide ratios. To determine protein expression levels,
a fold change of >2.0 or <0.5 between any pair from the 4
sample types, ie, PL LE2, PL HE2, FF LE2, and FF HE2 were
respectively set for up- and down-regulated proteins. The
paired comparisons made were PL HE2 and PL LE2, FF HE2
and FF LE2, PL HE2 and FF HE2, and PL LE2 and FF LE2.
Functional analysis was performed for all identiﬁed proteins and for up- and down-regulated proteins.
2.8. Bioinformatic analysis of identiﬁed proteins
The PANTHER (Protein Analysis Through Evolutionary
Relationships) classiﬁcation system [14] was used to categorize the up- and down-regulated proteins based on their
molecular function (MF), biological process (BP), and cellular component (CC)/localization. Pathway analysis was per-

Fig. 1. The number of up- and down-regulated proteins (y-axis) after
comparisons between any 2 samples (x-axis). The number of proteins in
each category is shown on the bar.

formed using the Database for Annotation, Visualization
and Integrated Discovery (DAVID) [15]. Pathway plot was
derived using Kyoto Encyclopedia of Genes and Genomes
(KEGG) [16].
3. Results
3.1. General information on iTRAQ analysis
A total of 231 proteins matched to 793 unique peptides
were identiﬁed with high conﬁdence (FDR of 5% or less)
and were subsequently included in further analysis. From
the 231 proteins, 221 (91.8%) were commonly identiﬁed
and quantiﬁed in both PL and FF, 12 were uniquely in PL,
and 7 uniquely in FF.. Approximately 61% (140/231) of proteins were identiﬁed by one unique peptide and ~39% by 2
unique peptides up to 47 unique peptides. About one third
of proteins identiﬁed by one unique peptide were identiﬁed at 99% conﬁdence. Analysis of the distribution of the
sequence coverage of the detected peptides of the proteins
found ~53% (123/231) of identiﬁed proteins had greater
than 5% coverage. The molecular mass of the identiﬁed
proteins ranged from 10.3 to 3811.5 kDa (110.4 ± 266.6
kDa) with majority of the proteins (~60%) between 20 to
80 kDa. Protein pI values ranged from 4.41 to 11.05. Several
of the proteins identiﬁed herein have been previously reported as components of bovine PL and/or FF [3,17]. A total
of 103 proteins signiﬁcantly changed abundance as deﬁned
by fold change. The extents of fold change are shown Supplement Table 1.
3.2. Comparative analysis of protein expression in plasma
and follicular ﬂuid
Paired comparisons were made to determine differences in protein expression between any pair from the 4
samples: PL HE2, PL LE2, FF HE2, and FF LE2. Fig. 1 depicts the different paired comparisons and the number of
up- and down-regulated proteins obtained in each analysis. Up- and down-regulated proteins were determined using a ratio fold-change of >2.0 or <0.5 between any 2 of
the 4 sample types. Comparison between same ﬂuid type
(ie, PL HE2 and PL LE2 or FF HE2 and FF LE2) revealed 9
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Fig. 2. Overlap of number of up-regulated (A) and down-regulated (B) proteins in PL and FF after paired analyses.

down-regulated and 7 up-regulated proteins in PL HE2
compared to PL LE2 and 10 down-regulated and 15 upregulated proteins in FF HE2 compared to FF LE2. Comparison between PL and FF showed more proteins up-regulated
in PL compared to FF. Each PL and FF pair, (ie, PL LE2 and
FF LE2; PL
HE2 and FF HE2) revealed 51 up-regulated proteins in
PL. Twenty-one proteins were down-regulated in PL LE2
compared to FF LE2 whereas 27 proteins were downregulated in the PL HE2 compared to the FF HE2. Thirtynine up-regulated proteins and 11 down-regulated proteins
were commonly identiﬁed from both PL and FF paired
analyses. Overlaps of numbers of proteins from the different paired comparisons are depicted in Fig. 2.
The iTRAQ ratio value of a protein is indicative of the
extent of up or down regulation of the protein in a sample. Comparison of FF HE2 to FF LE2 identiﬁed keratin
type II cytoskeletal 7 (KRT7), serum albumin (ALB), and
cytokine receptor like factor 3 (CRLF3) as the top 3 upregulated proteins and hemoglobin subunit alpha (HBA),
hemoglobin subunit beta (HBB), and ubiquitin protein ligase E3 component n-recognin 4 (UBR4) as the top 3 downregulated proteins in the FF HE2. Suppressor of G2 allele
of SKP1 homolog (SUGT1), C8G protein (C8G), and serglycin (SRGN) were the top 3 up-regulated proteins and
DDB1 and CUL4 associated factor 5 (DCAF5), transmembrane protein 186 (TMEM186), and haptoglobin (HP) the
top 3 down-regulated proteins in PL HE2 compared to PL
LE2.
3.3. Functions of identiﬁed proteins
To determine the functions of all proteins showing
expression changes, the up- and down-regulated proteins
derived from all paired analyses were compiled (103 in
total) and functional analysis performed using PANTHER
classiﬁcation system. The up- and down-regulated proteins
were categorized into molecular function (MF), biological
process (BP), and cellular component (CC; Fig. 3). The majority of the MF proteins were binding (52%) and catalytic
activity (40.0%). The BP proteins were categorized into
cellular component cellular process (33.3%), metabolic process (20.5%), organization or biogenesis (6.8%), localization

(6.8%), biological regulation (6.8%), developmental process
(6.8%), multicellular organismal process (6.0%), response
to stimulus (5.1%), biological adhesion (4.3%), immune
system process (2.6%), and locomotion (0.9%). Analysis of
the CC proteins revealed the majority of the up and downregulated proteins were localized in the cell (31.8%), the
extracellular region (22.7%) and organelle (21.2%).
3.4. Enriched pathways
Database for Annotation, Visualization and Integrated Discovery (DAVID) was used to determine the pathways associated with the up- and down-regulated proteins
in PL and FF. The databases within the DAVID platform
searched were KEGG and Reactome [18] databases. Statistical enriched pathway, P < 0.05, is based on Modiﬁed
Fisher Exact (EASE Score). Results from KEGG showed
the complement and coagulation cascades were enriched
(P = 3.5 × 10−14 ; Fig. 4). The search in Reactome supported these enriched pathways by identifying platelet
degranulation (P = 8.2 × 10−9 ), intrinsic pathway of ﬁbrin
clot formation (P = 1.4 × 10−5 ), common pathway of ﬁbrin
clot formation (P = 2.4 × 10−4 ), and scavenging of heme
from plasma (P = 6.0 × 10−3 ) as the main pathways.
4. Discussion
Results of the present study support the hypothesis
that increased circulating concentrations of E2 in bovine
FF from dominant follicles is associated with greater abundance of proteins involved in ﬁnal stages of folliculogenesis and ovulation. When evaluating reproductive success
among cows, expression of estrus or elevated preovulatory concentrations of E2 has been reported as a potential
biomarker of fertility. Estradiol is critical to the development and maturation of ovarian follicles [5,7]. Concentration of E2 in PL and/or FF has been positively correlated to
increased oocyte quality, fertilization and subsequent embryo quality [19], increased follicle size, [8] and improved
pregnancy success [20]. Considering the vital role of proteins in cell function and regulation, this study examined
the associations between E2 and protein abundance in FF
and PL. Both ﬂuids were evaluated because of the significant similarities between PL and FF proteins that results
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Fig. 3. PANTHER analysis of up- and down-regulated proteins identiﬁed in bovine plasma (PL) and follicular ﬂuid (FF) containing low and high preovulatory
E2. The up- and down-regulated proteins were compiled from PL HE2/PL LE2, FF HE2/FF LE2, PL LE2/FF LE2, and PL HE2/FF HE2 analyses. Proteins were
classiﬁed according to (A) molecular function, (B) cellular localization, and (C) biological processes.

from the number of PL proteins capable of crossing the
blood-follicular barrier during folliculogenesis [21,22].
A total of 103 proteins signiﬁcantly changed abundance
as deﬁned by fold change with HE2 or LE2. The number
and degree of fold change of proteins from the comparison
between HE2 and LE2 in FF was greater than the corresponding PL comparison. This suggests preovulatory circulating concentration of E2 has a greater impact on FF proteome than on PL proteome. This is not surprising as E2
is produced by the GCs of ovarian follicles [6,23] and FF is
the immediate environment of the developing follicle and
oocyte. The only predominant protein in PL HE2 that was
also predominant in the FF HE2 when compared to the respective LE2 samples was KRT7 a member of the keratin
gene family. The function of KRT7 is reported to be building structure integrity within complexes. Keratin genes are
usually synthesized in pairs consisting of one type I and
one type II as both are necessary to for an intermediate ﬁlament [24,25]. The presented data supports KRT7 involve-

ment in developing follicles and possibly eliciting similar
structural functions modulated by E2 in FF.
Because of the known impacts of E2 on pregnancy success, it is important to evaluate the results of this study in
2 different ways. The ﬁrst is to determine if there are proteins that could be impacting the production of E2 by the
dominant follicle. The second is to determine the impact
that E2 is having on preparing the female for pregnancy
success.
In evaluating proteins that could be impacting the production of E2 by the dominant follicle, PANTHER analysis
revealed the up- and down-regulated proteins had multifunctional roles, but cellular process and metabolic process were the predominant functions. Developing ovarian follicles undergo a series of coordinated cellular processes that induce morphological and functional changes
within the follicle, leading to cell differentiation and oocyte
development [26]. Further analysis in PANTHER showed
the proteins under cellular function were involved in cell
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Fig. 4. Up-regulated (red) and down-regulated (pink) proteins involved in the complement and coagulation cascades identiﬁed in this study. Up- and downregulated in plasma (PL) compared to follicular ﬂuid (FF): Alpha-2-macroglobulin (A2M), coagulation factor V (F5), coagulation factor XIII A chain (F13),
complement C1s (C1S), complement C6 (C6), alpha-1-antiproteinase (A1AT or SERPINA1), plasma serine protease inhibitor (PCI or SERPINA5), factor XIIa
inhibitor precursor (C1INH or SERPING1), complement C8 gamma chain (C8G; this was also up-regulated in PL HE2 compared to PL LE2), and ﬁbrinogen
(ﬁbrinogen alpha chain (FGA), ﬁbrinogen beta chain (FGB), and ﬁbrinogen gamma chain (FGG)). Fibrinogen is a ligand of complement receptor types 3 and
4 (CR3 and CR4; orange). Up-regulated in FF HE2 compared to FF LE2: coagulation factor XII (F12). (For interpretation of the references to color in this
ﬁgure legend, the reader is referred to the Web version of this article.)

communication (52.4%), cellular component movement
(23.8%), cell growth (4.8%), cell cycle (14.3%), and chromosome segregation (4.8%). Coordinated communications between the granulosa, cumulus, thecal cells, and the oocytes
is critical for successful folliculogenesis and the development of oocytes capable for ovulation and fertilization
[27]. Of these communication between the oocyte and
GCs is considered the most signiﬁcant for growth regulation and maturation of the oocyte and follicular luteinization. The proteins linked to cell communication identiﬁed in this study included inhibin alpha chain (INHA),
ﬁbronectin 1 transcript variant (FN1), ﬁbrinogen gamma
chain (FGG), ﬁbrinogen beta chain (FGB), lumican (LUM),
synaptotagmin-12 (SYT12), regulating synaptic membrane
exocytosis 2 (RIMS2) and KRAS proto-oncogene, GTPase
(KRAS). These proteins play vital roles in follicle growth
and maturation.
Folliculogenesis is highly regulated by gonadotropins
and sex hormones. The secretions of these hormones are
in turn regulated by a number of proteins. Inhibin alpha
is one such protein involved in the regulation of FSH secretion. Speciﬁcally, INHA selectively inhibits FSH secretion
from the pituitary in a negative-feedback mechanism [28].

The decline in FSH results in circulating concentrations
that can only be utilized by the largest follicle, thereby
enhancing its growth to become the DF. The inability of
smaller follicles to utilize the low circulating concentrations of FSH inhibits their growth [29,30]. Inhibin alpha
was highly down-regulated in PL compared to FF with
lower abundance in the high E2 pair (PL HE2/FF HE2;
iTRAQ ratio 0.062) than the low E2 pair (PL LE2/FF LE2;
iTRAQ ratio 0.079). The elevated INHA concentration in FF
from high E2 is consistent with the vital roles of INHA and
E2 in the decline of FSH observed during follicular deviation [29,30]. Apart from its role in regulating FSH secretion, INHA is also a critical regulator of different cellular
processes including differentiation, cell migration, proliferation, and apoptosis [31].
The proteins FN1, FGB, FGG, and apolipoprotein R were
classiﬁed under biological adhesion by PANTHER. Cell adhesion leads to alterations in cell shape and motility that
are required for different cellular functions during folliculogenesis and the development of a competent oocyte
[32,33]. Fibrinogen and FN1 have been reported to increase proliferation in several cell types. Speciﬁcally, FN1
has been reported to stimulate proliferation of ovarian GCs
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[34]. Successful ovulation and capture of the oocyte by the
oviduct and subsequent transport through the oviduct necessitates formation and expansion of the cumulus celloocyte (COC) matrix [35]. Stabilization and expansion of
the COC matrix involves binding of several proteins including FN1, versican core protein (VCAN), and laminin [36].
Furthermore, successful folliculogenesis requires adequate
regulation of cellular apoptosis, and engulfment and cell
motility 1 (ELMO1) has been reported to promote cellular
apoptosis [37]. The down-regulation of ELMO1 in FF HE2
compared to FF LE2 supports the idea of decreased apoptosis in preovulatory follicles that are capable of producing elevated concentrations of estradiol. The suppression
of ELMO1 in the presence of E2 at the preovulatory stage
seems more localized in FF since it was more predominant
in PL HE2 when compared to PL LE2.
In the opposite direction vitamin D-binding protein
(GC) was down-regulated in the FF of HE2 animals compared to the FF in LE2 animals. Folliculogenesis involves
proteins that transport and/or maintain substances including cells, cell components, metabolites and proteins in
speciﬁc locations of action. Proteins involved in this process were categorized under localization. Such proteins included GC. GC is the main protein involved in the transport of 25-hydroxyvitamin D (25(OH)D), the precursor of
the active form of vitamin D and the recognized optimal
indicator of vitamin D status. Vitamin D level is therefore
majorly contributed by GC level [38,39]. Based on the free
hormone hypothesis that protein-bound hormones are not
biologically available and that unbound hormones are biologically active, down-regulation of GC as found in this
study can indicate more bioavailable 25(OH)D [38]. Apart
from its well-known role in bone morphology, vitamin D is
increasing being viewed as vital for regulation of reproduction physiology. Our data asserts a regulation of vitamin D
by E2.
The second way to examine these data is to determine
the impact that estradiol is having on preparing the female for pregnancy. The immune system in the reproductive tract plays a critical role in simultaneously providing a
protective microenvironment to support successful reproduction processes and conferring protection against potential pathogens. The presence of immune system mediators
during periovulatory follicle differentiation, ovulation and
subsequent formation of the corpus luteum suggests active involvement of the immune system in these processes
[40]. In fact, folliculogenesis and ovulation are viewed as
a hormone-induced inﬂammatory processes [41]. Sex hormones, E2 and progesterone, signiﬁcantly regulate the reproductive immune system cells, tissues and molecules
[42]. This is supported by the results of this study demonstrating changes of immune-related proteins in the presence of high and low E2. Haptoglobin and immunoglobulin lambda-like polypeptide 1 were down-regulated in both
plasma and follicular ﬂuid while SRGN was up-regulated in
the plasma of HE2 animals compared to LE2 animals.
Pathway analysis revealed that the complement and coagulation cascades were the predominant pathways, consistent with previous studies on FF [3,43]. Stage of follicle
development seems to regulate the proteins involved in coagulation pathway. Proteins involved in coagulation were

found down-regulated in the predeviation, early deviation
and preovulatory stages and up-regulated in later deviation
to postdeviation stages [3]. Here, the coagulation and complement pathway involved 13 proteins showing different
levels of expression changes, supporting a dependence on
individual protein roles in the pathway. The predominance
of the complement and coagulation cascades supports the
view that the follicle development and ovulation are hemorrhagic and inﬂammatory induced events, and increased
concentrations of estradiol are preparing the body for this
event.
The complement cascade and coagulation cascade are
closely related and each activates the other in a reciprocal way. For instance, activated platelets can activate the
classical and alternative complement pathways. Thrombin,
coagulation factors FIXa, FXa, FXIa, and plasmin can activate C3 and C5. F12a can activate C1qrs complex to activate
the classical complement pathway. Conversely, mannanbinding lectin associated serine protease 2 (MASP-2) and
the ﬁnal stage complement complex C5b–9 are able to
generate thrombin through direct cleavage of prothrombin.
Thrombin is a vital coagulation component that converts
ﬁbrinogen to ﬁbrin.
Coagulation factor 12 (F12) is the ﬁrst component of
the coagulation pathway and its activation triggers the intrinsic pathway of the coagulation system [44]. Coagulation factor 12 was up-regulated in FF HE2 compared to
FF LE2, indicating a greater inﬂuence of E2 on F12 in
FF. Five other proteins were down-regulated in PL compared to FF namely alpha-1 antitrypin (A1AT), plasma serine protease inhibitor (PCI), factor XIIa inhibitor precursor
(C1INH), complement C6 (C6), and complement C8 gamma
chain (C8G). Alpha-1 antitrypin expression in FF HE2 was
about double that in FF LE2 when compared to the corresponding PL samples. Alpha-1 antitrypin, C1INH and PCI
are protease inhibitors belonging to the SERPIN superfamily. The SERPINs regulate a wide range of proteins including those involved in the coagulation, ﬁbrinolysis, and
complement pathways [45,46]. In conclusion, E2 concentrations associated with changes in abundance of several
proteins in both PL and FF. The relative changes of several
of the proteins are consistent with their function in follicle
growth and maturation, and in preparing the reproductive
tract for pregnancy success. Furthermore, the coagulation
and complement cascades are enriched during bovine follicle development and support the view that folliculogenesis
and ovulation are hemorrhagic events.
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